Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
84,017
+4,756
+6% +$124K 0.59% 57
2026
Q1
$2.23M Buy
79,261
+6,680
+9% +$178K 0.69% 54
2025
Q4
$1.81M Sell
72,581
-9,938
-12% -$251K 0.55% 59
2025
Q3
$2.1M Sell
82,519
-1,130
-1% -$27.9K 0.64% 56
2025
Q2
$2.03M Buy
83,649
+2,866
+4% +$66.8K 0.66% 56
2025
Q1
$2.05M Buy
80,783
+14,753
+22% +$386K 0.72% 53
2024
Q4
$1.75M Buy
66,030
+372
+0.6% +$10.1K 0.67% 53
2024
Q3
$1.9M Buy
+65,658
New +$1.92M 0.74% 51
2023
Q1
Sell
-32,913
Closed -$1.69M 58
2022
Q4
$1.69M Sell
32,913
-384
-1% -$18.4K 1.04% 34
2022
Q3
$1.46M Buy
33,297
+1,891
+6% +$91.9K 0.93% 37
2022
Q2
$1.65M Sell
31,406
-341
-1% -$17.4K 1.07% 37
2022
Q1
$1.64M Sell
31,747
-676
-2% -$35.1K 0.88% 38
2021
Q4
$1.92M Buy
32,423
+630
+2% +$31.2K 0.96% 37
2021
Q3
$1.37M Buy
31,793
+623
+2% +$27.6K 0.8% 41
2021
Q2
$1.22M Buy
31,170
+86
+0.3% +$3.34K 0.73% 43
2021
Q1
$1.13M Buy
31,084
+2,016
+7% +$71.6K 0.74% 40
2020
Q4
$1.07M Sell
29,068
-1,854
-6% -$68K 0.75% 39
2020
Q3
$1.08M Buy
30,922
+529
+2% +$18.5K 0.83% 38
2020
Q2
$943K Buy
30,393
+21,415
+239% +$728K 0.81% 36
2020
Q1
$278K Sell
8,978
-290
-3% -$9.88K 0.4% 30
2019
Q4
$345K Buy
+9,268
New +$330K 0.33% 44

Other funds holding PFE

Hixon Zuercher's PFE Position: Q2 2026 in Review

Hixon Zuercher increased its Pfizer (PFE) stake by 6% in Q2 2026, buying an estimated $124K and bringing the position to 84,017 shares worth $2.02M. The position accounts for 0.59% of the portfolio, ranked #57.

Hixon Zuercher first reported a position in PFE in Q4 2019 and has held it in 21 quarters since. The position peaked at $2.23M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hixon Zuercher held 84,017 shares of Pfizer worth $2.02M as of Q2 2026.
  • Hixon Zuercher bought 4,756 Pfizer shares in Q2 2026, an estimated $124K.
  • Pfizer made up 0.59% of Hixon Zuercher's portfolio in Q2 2026, its #57 holding.
  • Hixon Zuercher first reported a position in Pfizer in Q4 2019 and has held it in 21 quarters since.
  • Hixon Zuercher's Pfizer position peaked at $2.23M in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hixon Zuercher's 13F filing for Q2 2026, filed 20 Jul 2026.